The Zacks Analyst Blog Highlights: GW, Innovative Industrial, Canopy, Aurora And KushCo

 | May 01, 2019 10:13PM ET

For Immediate Release

Chicago, IL – May 2, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include GW Pharmaceuticals plc (NASDAQ:GWPH) , Innovative Industrial Properties Inc. (NYSE:IIPR) , Canopy Growth Corp. (NYSE:CGC) , Aurora Cannabis Inc. (TO:ACB) and KushCo Holdings Inc. (OTC:KSHB) .

Here are highlights from Wednesday’s Analyst Blog:

Invest Carefully in Rosy -- but Risky -- Marijuana Industry

The marijuana industry has strong potential especially after legalization for recreational and medicinal use. Moreover, the industry is enjoying benefits of expansion into other industries like food, beverage, tobacco and cosmetics.

The much-awaited Cannabis Banking Bill was finally passed by the House Financial Services Committee on Mar 28. This opens up avenues for legal and effective financing for marijuana companies in the United States.

However, investors should be careful as several stocks of this industry have already skyrocketed even as the industry has been tagged as highly volatile.

Cannabis Banking Bill: A Key Catalyst

On Mar 28, the House Financial Services Committee voted 45-15 in favor of passing the Secure and Fair Enforcement Banking Act of 2019 or the SAFE Banking Act. The bill seeks to safeguard the process of financial lending to cannabis companies in the United States. This would not only protect the industry’s credit lines but also aid cannabis ancillary industries in the country. The ancillary sector has been suffering from financial uncertainties associated with the legal status of marijuana in the past.

Cannabis is getting approval from many U.S. states for recreational uses, in addition to medical usage. Though pot remains entirely illegal at the federal level, currently 47 U.S. states offer some form of legalized marijuana for sale.

Strong Market Potential

Research firm Euromonitor has estimated that the American market for legal marijuana products will reach $20 billion by 2020 from a mere $5.4 billion in 2015. According to the Arcview Market Research, the U.S. legal cannabis market is expected to reach $23 billion by 2022. Research firm Cowen projected that the market size of the U.S. legal cannabis industry will reach $75 billion in by 2030, surpassing the carbonated soft drink market in 2017.

Per a study conducted by Colorado cannabis consulting firm Freedman & Koski, Illinois’ annual marijuana market could be between $1.69 billion and $2.58 billion. Overall, U.S. consumer spending on legal cannabis is expected to reach $22.2 billion by 2022, while Canadian spending is estimated to hit $5.9 billion, per a January report by Arcview Market.

Extremely Volatile Industry

The marijuana industry is considered extremely volatile. Most of these companies are in their early stages of development and characterized as risky for investors. Even a minor negative development may cause major stock price fluctuations.

Notably, in October 2018, the news of supply shortages resulted in panic selling as investor’s look to offload risky stocks. According to some industry experts, 5-10% share price volatility daily should not be considered as unnatural for this industry.

Potential Winners

Cannabis stocks are solid long-term bets. Of these, stocks with a Zacks Rank #3 (Hold) or better and solid long-term growth potential are worth trying out despite the latent risks. We have narrowed down our search to five such stocks.

GW Pharmaceuticals plc a biopharmaceutical company, focuses on discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. The stock carries a Zacks Rank #2 (Buy). You can see Zacks Investment Research

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes